Gastroenterology Focus Will Unlock Enduring Market Potential
AN
AnalystConsensusTarget
Not Invested
Consensus Narrative from 8 Analysts
Published
09 May 25
Updated
15 Aug 25
AnalystConsensusTarget's Fair Value
US$20.50
48.9% undervalued intrinsic discount15 Aug
US$10.47
1Y
-20.1%7D
11.4%